DR. THADDEUS P. DRYJA, MD
Medical Practice at Charles St, Boston, MA
License number
Massachusetts 41891
Category
Medical Practice
Type
Ophthalmology
License number
Massachusetts 41891
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
243 Charles St, Boston, MA 02114
Phone
(617) 573-3319
(617) 573-4458
(617) 573-4037 (Fax)
(617) 573-4458
(617) 573-4037 (Fax)
Organization information
See more information about THADDEUS P. DRYJA at bizstanding.comMassachusetts Eye & Ear Associate - Thaddeus P Dryja MD
243 Charles St, Boston, MA 02114
Categories:
Ophthalmology Physicians & Surgeons, Pathology Physicians & Surgeons, Physicians & Surgeons
Phone:
(617) 523-5498 (Phone)
Professional information
Dr. Thaddeus P Dryja, Boston MA - MD (Doctor of Medicine)
Specialties:
Ophthalmology, Clinical Molecular Genetics
Address:
MASSACHUSETTS EYE AND EAR INFIRMARY
243 Charles St, Boston 02114
(617) 573-7900 (Phone), (617) 573-3914 (Fax)
243 Charles St, Boston 02114
(617) 573-7900 (Phone), (617) 573-3914 (Fax)
Certifications:
Clinical Molecular Genetics, 1993, Ophthalmology, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Yale University
Graduated: 1976
Waterbury Hosp
Massachusetts Eye and Ear Infirmary
Chldrns Hosp
Mass Ee Infirm
Yale University
Graduated: 1976
Waterbury Hosp
Massachusetts Eye and Ear Infirmary
Chldrns Hosp
Mass Ee Infirm
Thaddeus P Dryja, Boston MA
Specialties:
Ophthalmologist
Address:
243 Charles St, Boston, MA 02114
Education:
Yale University, School of Medicine - Doctor of Medicine
Massachusetts Eye & Ear Infirmary - Fellowship - Ophthalmic Pathology
Massachusetts Eye & Ear Infirmary - Fellowship - Ophthalmic Pathology
Board certifications:
American Board of Medical Genetics Certification in Clinical Molecular Genetics (Medical Genetics), American Board of Ophthalmology Certification in Ophthalmology
Mutations In Nucleic Acid Molecules Encoding 11-Cis Retinol Dehydrogenase, The Mutated Proteins, And Uses Thereof
US Patent:
6372463, Apr 16, 2002
Filed:
May 6, 1999
Appl. No.:
09/306538
Inventors:
András Simon - Stockholm, SE
Ulf Eriksson - Stockholm, SE
Thaddeus P. Dryja - Boston MA
Eliot L. Berson - Boston MA
Ulf Eriksson - Stockholm, SE
Thaddeus P. Dryja - Boston MA
Eliot L. Berson - Boston MA
Assignee:
The President Fellows of Harvard College - Cambridge MA
Massachusette Eye Ear Infirmary - Boston MA
Ludwig Institute for Cancer Research - New York NY
Massachusette Eye Ear Infirmary - Boston MA
Ludwig Institute for Cancer Research - New York NY
International Classification:
C12N 904
US Classification:
435190, 4352523, 4353201, 435 26, 536 232, 530350
Abstract:
The invention relates to mutations in the gene encoding 11-cis retinal dehyrogenase. The mutations in the gene and in the resulting encoded protein are correlated to ocular disorders, such as fundus albipunctatus.
Mutations In Nucleic Acid Molecules Encoding 11-Cis Retinol Dehydrogenase, The Mutated Proteins, And Uses Thereof
US Patent:
2002004, Apr 11, 2002
Filed:
Jun 13, 2001
Appl. No.:
09/880427
Inventors:
Andras Simon - Stockholm, SE
Ulf Eriksson - Stockholm, SE
Thaddeus Dryja - Boston MA, US
Eliot Berson - Boston MA, US
Ulf Eriksson - Stockholm, SE
Thaddeus Dryja - Boston MA, US
Eliot Berson - Boston MA, US
International Classification:
C12N009/04, C07H021/04, C12N005/06, C12P021/02
US Classification:
435/190000, 435/069100, 536/023200, 435/325000
Abstract:
The invention relates to mutations in the gene encoding 11-cis retinal dehyrogenase. The mutations in the gene and in the resulting encoded protein are correlated to ocular disorders, such as fundus albipunctatus.
Method For Determining Eye Disorders By Determining Mutations In 11-Cis Retinol Dehydrogenase
US Patent:
2002011, Aug 29, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/991980
Inventors:
Andras Simon - Stockholm, SE
Ulf Eriksson - Stockholm, SE
Thaddeus Dryja - Boston MA, US
Eliot Berson - Boston MA, US
Ulf Eriksson - Stockholm, SE
Thaddeus Dryja - Boston MA, US
Eliot Berson - Boston MA, US
International Classification:
C12N009/04, C12P007/40, C07H021/04, C12P021/02, C12N005/06
US Classification:
435/190000, 536/023200, 435/069100, 435/136000, 435/325000, 435/320100
Abstract:
The invention relates to mutations in the gene encoding 11-cis retinal dehyrogenase. The mutations in the gene and in the resulting encoded protein are correlated to ocular disorders, such as fundus albipunctatus.